GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » Gross Margin %

Cresco Labs (XCNQ:CL) Gross Margin %

: 51.08% (As of Dec. 2023)
View and export this data going back to 1991. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Cresco Labs's Gross Profit for the three months ended in Dec. 2023 was C$129 Mil. Cresco Labs's Revenue for the three months ended in Dec. 2023 was C$253 Mil. Therefore, Cresco Labs's Gross Margin % for the quarter that ended in Dec. 2023 was 51.08%.


The historical rank and industry rank for Cresco Labs's Gross Margin % or its related term are showing as below:

XCNQ:CL' s Gross Margin % Range Over the Past 10 Years
Min: 43.4   Med: 48.3   Max: 49.86
Current: 47.01


During the past 13 years, the highest Gross Margin % of Cresco Labs was 49.86%. The lowest was 43.40%. And the median was 48.30%.

XCNQ:CL's Gross Margin % is ranked better than
50.25% of 991 companies
in the Drug Manufacturers industry
Industry Median: 46.83 vs XCNQ:CL: 47.01

Cresco Labs had a gross margin of 51.08% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Cresco Labs was 0.00% per year.


Cresco Labs Gross Margin % Historical Data

The historical data trend for Cresco Labs's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.86 43.40 49.45 48.30 47.01

Cresco Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.94 44.22 43.81 49.14 51.08

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Gross Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Gross Margin % falls into.



Cresco Labs Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Cresco Labs's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=486.2 / 1034.219
=(Revenue - Cost of Goods Sold) / Revenue
=(1034.219 - 548.069) / 1034.219
=47.01 %

Cresco Labs's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=129 / 252.539
=(Revenue - Cost of Goods Sold) / Revenue
=(252.539 - 123.55) / 252.539
=51.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cresco Labs  (XCNQ:CL) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cresco Labs had a gross margin of 51.08% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Cresco Labs Gross Margin % Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (XCNQ:CL) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.